US 10,376,533 B2
Compositions and methods for treating viral infections
Radhakrishnan P. Iyer, Shrewsbury, MA (US); and Seetharamaiyer Padmanabhan, Lexington, MA (US)
Assigned to Spring Bank Pharmaceuticals, Inc., Hopkinton, MA (US)
Filed by SPRING BANK PHARMACEUTICALS, INC., Milford, MA (US)
Filed on Dec. 2, 2016, as Appl. No. 15/367,552.
Application 15/367,552 is a continuation of application No. 14/823,359, filed on Aug. 11, 2015, granted, now 9,539,276.
Application 14/823,359 is a continuation of application No. 13/800,931, filed on Mar. 13, 2013, granted, now 9,138,442, issued on Sep. 22, 2015.
Application 13/800,931 is a continuation of application No. 12/897,389, filed on Oct. 4, 2010, granted, now 8,404,651, issued on Mar. 26, 2013.
Application 12/897,389 is a continuation of application No. PCT/US2009/039424, filed on Apr. 3, 2009.
Claims priority of provisional application 61/074,421, filed on Jun. 20, 2008.
Claims priority of provisional application 61/072,794, filed on Apr. 3, 2008.
Claims priority of provisional application 61/072,799, filed on Apr. 3, 2008.
Prior Publication US 2017/0304344 A1, Oct. 26, 2017
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 43/04 (2006.01); A61K 31/70 (2006.01); A61K 31/7076 (2006.01); A61K 31/7084 (2006.01); A61K 31/7056 (2006.01); C07H 19/04 (2006.01); C07H 19/052 (2006.01)
CPC A61K 31/7076 (2013.01) [A61K 31/7084 (2013.01); A61K 31/70 (2013.01); A61K 31/7056 (2013.01); C07H 19/04 (2013.01); C07H 19/052 (2013.01); Y02A 50/385 (2018.01); Y02A 50/393 (2018.01)] 3 Claims
 
1. A method of treating an HCV infection comprising administering to a patient in need of such treatment an effective amount of a compound of formula:

OG Complex Work Unit Drawing
or a pharmaceutically acceptable salt, ester, stereoisomer, tautomer, solvate, or combination thereof, wherein the HCV infection is a co-infection with a disease other than HCV.